TUBOCURARINE CHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for tubocurarine chloride and what is the scope of patent protection?
Tubocurarine chloride
is the generic ingredient in one branded drug marketed by Bristol Myers Squibb, Hospira, and Lilly, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.Summary for TUBOCURARINE CHLORIDE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 3 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 16 |
| Patent Applications: | 34 |
| DailyMed Link: | TUBOCURARINE CHLORIDE at DailyMed |
Medical Subject Heading (MeSH) Categories for TUBOCURARINE CHLORIDE
Anatomical Therapeutic Chemical (ATC) Classes for TUBOCURARINE CHLORIDE
US Patents and Regulatory Information for TUBOCURARINE CHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira | TUBOCURARINE CHLORIDE | tubocurarine chloride | INJECTABLE;INJECTION | 006095-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Lilly | TUBOCURARINE CHLORIDE | tubocurarine chloride | INJECTABLE;INJECTION | 006325-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bristol Myers Squibb | TUBOCURARINE CHLORIDE | tubocurarine chloride | INJECTABLE;INJECTION | 005657-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
